Published in Osteoporos Int on May 21, 2014
Vitamin D supplementation and fracture risk in adults: a new insight. Osteoporos Int (2014) 0.99
Short-term and long-term effects of osteoporosis therapies. Nat Rev Endocrinol (2015) 0.98
Vitamin D: is evidence of absence, absence of evidence? Osteoporos Int (2014) 0.97
Vitamin D and cardiovascular disease prevention. Nat Rev Cardiol (2016) 0.88
Role of vitamin D levels and vitamin D supplementation on bone mineral density in Klinefelter syndrome. Osteoporos Int (2015) 0.78
Vitamin D supplementation: less controversy, more guidance needed. F1000Res (2016) 0.77
Update on vitamin D: pros and cons. Clin Cases Miner Bone Metab (2015) 0.75
Response to letter to editor. Osteoporos Int (2014) 0.75
Understanding vitamin D deficiency. Age Ageing (2014) 0.75
Micronutrients, Essential Fatty Acids and Bone Health in Phenylketonuria. Ann Nutr Metab (2017) 0.75
Spectacular improvement in vitamin D status in elderly osteoporotic women: 8-year analysis of an osteoporotic population treated in a dedicated fracture liaison service. Osteoporos Int (2015) 0.75
Changes in bone mineral density related to changes in serum 25-OH vitamin D concentrations over a two-year period in postmenopausal women. Endocrine (2017) 0.75
Calcium plus vitamin D supplementation and the risk of fractures. N Engl J Med (2006) 12.09
Annual high-dose oral vitamin D and falls and fractures in older women: a randomized controlled trial. JAMA (2010) 11.59
Vitamin D3 and calcium to prevent hip fractures in the elderly women. N Engl J Med (1992) 9.86
Use of calcium or calcium in combination with vitamin D supplementation to prevent fractures and bone loss in people aged 50 years and older: a meta-analysis. Lancet (2007) 9.61
Vitamin D status and ill health: a systematic review. Lancet Diabetes Endocrinol (2013) 9.48
Fall prevention with supplemental and active forms of vitamin D: a meta-analysis of randomised controlled trials. BMJ (2009) 7.64
Interventions for preventing falls in older people living in the community. Cochrane Database Syst Rev (2012) 7.29
A pooled analysis of vitamin D dose requirements for fracture prevention. N Engl J Med (2012) 6.85
Effects of vitamin D supplements on bone mineral density: a systematic review and meta-analysis. Lancet (2013) 6.19
Fracture prevention with vitamin D supplementation: a meta-analysis of randomized controlled trials. JAMA (2005) 5.95
The effect of vitamin D supplementation on skeletal, vascular, or cancer outcomes: a trial sequential meta-analysis. Lancet Diabetes Endocrinol (2014) 5.40
Redefining vitamin D insufficiency. Lancet (1998) 5.26
Vitamin D with or without calcium supplementation for prevention of cancer and fractures: an updated meta-analysis for the U.S. Preventive Services Task Force. Ann Intern Med (2011) 3.71
Relationship between serum parathyroid hormone levels, vitamin D sufficiency, and calcium intake. JAMA (2005) 3.16
An international comparison of serum 25-hydroxyvitamin D measurements. Osteoporos Int (1999) 3.07
Vitamin D supplementation and falls: a trial sequential meta-analysis. Lancet Diabetes Endocrinol (2014) 2.85
Combined calcium and vitamin D3 supplementation in elderly women: confirmation of reversal of secondary hyperparathyroidism and hip fracture risk: the Decalyos II study. Osteoporos Int (2002) 2.82
Randomized controlled trial of calcium in healthy older women. Am J Med (2006) 2.78
Dose response to vitamin D supplementation in postmenopausal women: a randomized trial. Ann Intern Med (2012) 2.74
The nonskeletal effects of vitamin D: an Endocrine Society scientific statement. Endocr Rev (2012) 2.71
Patient level pooled analysis of 68 500 patients from seven major vitamin D fracture trials in US and Europe. BMJ (2010) 2.67
Effect of calcium and cholecalciferol treatment for three years on hip fractures in elderly women. BMJ (1994) 2.61
Vitamin D and vitamin D analogues for preventing fractures associated with involutional and post-menopausal osteoporosis. Cochrane Database Syst Rev (2009) 2.58
Interventions for preventing falls in older people in nursing care facilities and hospitals. Cochrane Database Syst Rev (2010) 2.50
Is high dose vitamin D harmful? Calcif Tissue Int (2012) 2.43
The relation between acute changes in the systemic inflammatory response and plasma 25-hydroxyvitamin D concentrations after elective knee arthroplasty. Am J Clin Nutr (2011) 2.34
Calcitriol treatment is not effective in postmenopausal osteoporosis. Ann Intern Med (1989) 2.33
Vitamin D and cardiovascular outcomes: a systematic review and meta-analysis. J Clin Endocrinol Metab (2011) 2.11
Normocalcemia is maintained in mice under conditions of calcium malabsorption by vitamin D-induced inhibition of bone mineralization. J Clin Invest (2012) 2.10
Vitamin D metabolites and calcium absorption in severe vitamin D deficiency. J Bone Miner Res (2008) 2.00
Bone mineralization defects and vitamin D deficiency: histomorphometric analysis of iliac crest bone biopsies and circulating 25-hydroxyvitamin D in 675 patients. J Bone Miner Res (2010) 1.88
Clinical review: The effect of vitamin D on falls: a systematic review and meta-analysis. J Clin Endocrinol Metab (2011) 1.81
The relationship between bisphosphonate adherence and fracture: is it the behavior or the medication? Results from the placebo arm of the fracture intervention trial. J Bone Miner Res (2011) 1.70
Determinants of vitamin D status in older men living in a subtropical climate. Osteoporos Int (2006) 1.60
Is the vitamin d receptor found in muscle? Endocrinology (2010) 1.58
Iatrogenic osteomalacia and myopathy due to phosphate depletion. Br Med J (1974) 1.51
Where is the vitamin D receptor? Arch Biochem Biophys (2012) 1.45
Optimal vitamin D status: a critical analysis on the basis of evidence-based medicine. J Clin Endocrinol Metab (2013) 1.40
Prevalence of hypovitaminosis D in elderly women in Italy: clinical consequences and risk factors. Osteoporos Int (2003) 1.36
The nuclear vitamin D receptor controls the expression of genes encoding factors which feed the "Fountain of Youth" to mediate healthful aging. J Steroid Biochem Mol Biol (2010) 1.34
The effect of vitamin D on bone and osteoporosis. Best Pract Res Clin Endocrinol Metab (2011) 1.22
High-dose oral vitamin D3 supplementation in the elderly. Osteoporos Int (2008) 1.20
The effect of vitamin D on calcium absorption in older women. J Clin Endocrinol Metab (2012) 1.18
Intestinal vitamin D receptor is required for normal calcium and bone metabolism in mice. Gastroenterology (2008) 1.15
Determinants of vitamin D status in older women living in a subtropical climate. Osteoporos Int (2005) 1.08
Correlation of symptoms with vitamin D deficiency and symptom response to cholecalciferol treatment: a randomized controlled trial. Endocr Pract (2009) 1.07
Vitamin D does not increase calcium absorption in young women: a randomized clinical trial. J Bone Miner Res (2014) 0.98
Dietary calcium and phosphorus ratio regulates bone mineralization and turnover in vitamin D receptor knockout mice by affecting intestinal calcium and phosphorus absorption. J Bone Miner Res (2003) 0.98
Short-term effects on bone turnover markers of a single high dose of oral vitamin D₃. J Clin Endocrinol Metab (2012) 0.94
Does vitamin D improve muscle strength in adults? A randomized, double-blind, placebo-controlled trial among ethnic minorities in Norway. J Clin Endocrinol Metab (2013) 0.94
Vitamin D receptor in osteoblasts is a negative regulator of bone mass control. Endocrinology (2013) 0.94
An age-related decrease in creatinine clearance is associated with an increase in number of falls in untreated women but not in women receiving calcitriol treatment. J Clin Endocrinol Metab (2006) 0.93
Vitamin D intoxication causes hypercalcaemia by increased bone resorption which responds to pamidronate. Clin Endocrinol (Oxf) (1995) 0.92
Direct action of 1,25-dihydroxyvitamin D on bone: VDRKO bone shows excessive bone formation in normal mineral condition. J Steroid Biochem Mol Biol (2004) 0.91
Electromyography in nutritional osteomalacic myopathy. J Neurol Neurosurg Psychiatry (1976) 0.91
Transgenic expression of the human Vitamin D receptor (hVDR) in the duodenum of VDR-null mice attenuates the age-dependent decline in calcium absorption. J Steroid Biochem Mol Biol (2007) 0.90
Hypophosphatemia is responsible for skeletal muscle weakness of vitamin D deficiency. Arch Biochem Biophys (2010) 0.89
Women's Health Initiative clinical trials: interaction of calcium and vitamin D with hormone therapy. Menopause (2014) 0.89
Hip bone loss is attenuated with 1000 IU but not 400 IU daily vitamin D3: a 1-year double-blind RCT in postmenopausal women. J Bone Miner Res (2013) 0.88
Calcium risk-benefit updated--new WHI analyses. Maturitas (2013) 0.87
PTH level but not 25 (OH) vitamin D level predicts bone loss rates in the elderly. Osteoporos Int (2011) 0.87
Dose-dependent short-term effects of single high doses of oral vitamin D(3) on bone turnover markers. Calcif Tissue Int (2012) 0.86
Vitamin D concentration in 342 professional football players and association with lower limb isokinetic function. J Sci Med Sport (2013) 0.83
Effects of calcitriol or calcium on bone mineral density, bone turnover, and fractures in men with primary osteoporosis: a two-year randomized, double blind, double placebo study. J Clin Endocrinol Metab (2001) 0.81
Independent from muscle power and balance performance, a creatinine clearance below 65 ml/min is a significant and independent risk factor for falls and fall-related fractures in elderly men and women diagnosed with osteoporosis. Osteoporos Int (2009) 0.80
Bone mineral density and bone scintigraphy in adult Saudi female patients with osteomalacia. Saudi Med J (2004) 0.80
The effect of high-dose vitamin D supplementation on calciotropic hormones and bone mineral density in obese subjects with low levels of circulating 25-hydroxyvitamin d: results from a randomized controlled study. Calcif Tissue Int (2013) 0.78
Skeletal and hormonal responses to vitamin D supplementation during sunlight deprivation in Antarctic expeditioners. Osteoporos Int (2012) 0.75
Effect of calcium supplementation on hip fractures. Osteoporos Int (2008) 2.79
Cardiovascular effects of calcium supplementation. Osteoporos Int (2011) 1.96
A meta-analysis of the effect of lowering serum levels of GH and IGF-I on mortality in acromegaly. Eur J Endocrinol (2008) 1.82
Calcium supplements and cardiovascular risk in the Women's Health Initiative. Osteoporos Int (2013) 1.42
Comment on Kanis et al.: Pitfalls in the external validation of FRAX. Osteoporos Int (2012) 1.09
Role of ultrasound in the assessment of nodular thyroid disease. J Med Imaging Radiat Oncol (2009) 0.99
Re: The calcium scare: what would Austin Bradford Hill have thought? Osteoporos Int (2011) 0.89
The effect of calcium supplementation on serum urate: analysis of a randomized controlled trial. Rheumatology (Oxford) (2008) 0.88
The effect of treatments for osteoporosis on mortality. Osteoporos Int (2012) 0.87
The impact of dietary calcium intake and vitamin D status on the effects of zoledronate. Osteoporos Int (2012) 0.84
Calcium supplementation and vascular disease. Climacteric (2008) 0.81
The Auckland calcium study: 5-year post-trial follow-up. Osteoporos Int (2013) 0.78
Bone density in healthy men after cessation of calcium supplements: 20-month follow-up of a randomized controlled trial. Osteoporos Int (2014) 0.75
Response to letter to editor. Osteoporos Int (2014) 0.75
Calcium supplementation for older men and women? Osteoporos Int (2009) 0.75